EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

Effectiveness and cost-effectiveness of a collaborative deprescribing intervention of proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial

Sónia Romano iD, Luis Monteiro, José Pedro Guerreiro, João Braga Simões, António Teixeira Rodrigues, Nuno Lunet iD, Julian Perelman

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0298181 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Sónia Romano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Health Evaluation & Research/Infosaúde, National Association of Pharmacies (CEFAR-IF/ANF), Lisboa, Portugal. Hauptthemen laut MEDLINE: Deprescriptions, Proton Pump Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Worldwide, demographic ageing is a major social, economic and health challenge. Despite the increase in life expectancy, elderly often live with multiple chronic conditions, exposing them to multiple medications. Concerns have been raised about the growing issue of inappropriate long-term usage of proton-pump inhibitors (PPI), which have been associated with adverse outcomes and increased healthcare costs. Deprescribing is a recommended intervention to reduce or withdraw medicines that might be causing harm or might no longer be of benefit. This protocol details a trial to assess the effectiveness and cost-effectiveness of a collaborative deprescribing intervention of PPI among community-dwelling elderly, involving community pharmacists and general practitioners. Methods and analysis A pragmatic, multicentre, two-arm, non-randomised controlled trial of a structured PPI collaborative deprescribing intervention in the primary care setting with a 6-month follow-up will be conducted. Patients must be 65 years old or older, live in the community and have been using PPI for more than 8 weeks. We hypothesize that the intervention will reduce the PPI usage in the intervention group compared to the control group. The primary outcome is the successful discontinuation or dose decrease of any PPI, defined as a statistically significant absolute 20% reduction in medication use between the intervention and control groups at 3- and 6-month follow-ups. An economic evaluation will be conducted alongside the trial. This study was approved by the Ethics Research Committee of Nova Medical School, NOVA University of Lisbon and by the Ethics Committee from the Local Health Unit Alto Minho, Portugal.

Discussion

This pragmatic trial will provide evidence on the effectiveness and cost-effectiveness of a patient-centred collaborative deprescribing intervention in the community setting in Portugal. It will also inform improvements for the development of future multi-faceted interventions that aim to optimise medication for the community-dwelling elderly. Clinical trial registration ISRCTN 49637686 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeprescriptionsProton Pump InhibitorsAgedHumansCost-Benefit AnalysisIndependent LivingProtonsPragmatic Clinical Trials as TopicNon-Randomized Controlled Trials as Topic

Substanzen

Proton Pump InhibitorsProtons

Autor:innen und Institutionen

  • Centre for Health Evaluation & Research/Infosaúde, National Association of Pharmacies (CEFAR-IF/ANF), Lisboa, Portugal.
  • NOVA National School of Public Health, NOVA University Lisbon, Lisbon, Portugal.
  • Centre for Health Technology and Services Research, Faculty of Medicine of the University of Porto (CINTESIS), Porto, Portugal.
  • Unidade de Saúde Familiar Esgueira Mais, Aveiro, Portugal.
  • Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
  • Unidade de Saúde Familiar Terra da Nóbrega, Ponte da Barca, Portugal.

ORCID-Profile: Sónia Romano, Nuno Lunet

Zitieren

APA

Romano, S., Monteiro, L., Guerreiro, J. P., Simões, J. B., Teixeira Rodrigues, A., Lunet, N., & Perelman, J. (2024). Effectiveness and cost-effectiveness of a collaborative deprescribing intervention of proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0298181

Vancouver

Romano S, Monteiro L, Guerreiro JP, Simões JB, Teixeira Rodrigues A, Lunet N, et al. Effectiveness and cost-effectiveness of a collaborative deprescribing intervention of proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial. PLOS ONE. 2024. doi:10.1371/journal.pone.0298181

BibTeX
@article{Romano2024,
  author = {Romano, Sónia and Monteiro, Luis and Guerreiro, José Pedro and Simões, João Braga and Teixeira Rodrigues, António and Lunet, Nuno and Perelman, Julian},
  title = {Effectiveness and cost-effectiveness of a collaborative deprescribing intervention of proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0298181}
}
Kostenlos starten →